Bill Commons

MA S 730

in committee

An Act to increase the Medicaid life insurance exemption

Massachusetts · 2025-2026 Regular Session (194th General Court) · upper

Quick answers

Did MA S 730 pass?

Not yet. MA S 730 is in committee as of 2025-12-08 and has not come to a final vote. Latest recorded action (2025-12-08): Accompanied a study order, see S2814

What is MA S 730 about?

By Mr. Durant, a petition (accompanied by bill, Senate, No. 730) of Peter J. Durant and Bruce E. Tarr for legislation to increase the Medicaid life insurance exemption. Financial Services.

Who sponsors MA S 730?

Peter J. Durant is the primary sponsor of MA S 730, joined by 1 cosponsor.

Description

By Mr. Durant, a petition (accompanied by bill, Senate, No. 730) of Peter J. Durant and Bruce E. Tarr for legislation to increase the Medicaid life insurance exemption. Financial Services.

Introduced
Latest action
2025-12-08 — Accompanied a study order, see S2814
Bill type
bill
Last updated

Sponsors

  • Peter J. Durantprimary
  • Bruce E. Tarrcosponsor

Committees

Not provided by source.

Action timeline

  1. 2025-02-27

    Referred to the committee on Financial Services

    referral-committee

  2. 2025-02-27

    House concurred

  3. 2025-10-27

    Hearing scheduled for 11/04/2025 from 10:30 AM-01:30 PM in A-2

  4. 2025-12-08

    Accompanied a study order, see S2814

Versions

Documents

Votes

Not provided by source.

Related bills

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z

Inspect retained evidence for changes recorded after evidence tracking began:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=S 730. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.